A STUDY TO EVALUATE THE EFFECTS OF MULTIPLE ORAL DOSES OF BILASTINE, DESLORATADINE, AND LEVOCETIRIZINE ON PSYCHOMOTOR PERFORMANCE AND SALIVARY FLOW IN PATIENTS WITH CHRONIC URTICARIA ATTENDING DERMATOLOGY OUTPATIENT DEPARTMENT AT A TERTIARY CARE CENTER

Authors

  • IMRAN KHAN Department of Clinical Pharmacology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India. https://orcid.org/0000-0001-6101-245X
  • PADMAJA MEKALA Department of Clinical Pharmacology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India. https://orcid.org/0009-0002-0134-2486
  • ASIYA BEGUM Department of Dermatology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India. https://orcid.org/0009-0007-1083-477X
  • USHARANI PINGALI Department of Clinical Pharmacology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India
  • SUMEDH GK Department of Clinical Pharmacology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India https://orcid.org/0009-0009-1974-0440

DOI:

https://doi.org/10.22159/ajpcr.2025v18i3.53701

Keywords:

Bilastine,, Desloratadine, Levocetirizine,, Salivary flow, Psychomotor performance

Abstract

Objectives: Antihistamines are the most used systemically delivered medications for skin conditions that can inhibit cholinergic (muscarinic) receptors and block central H1 receptors leading to effects such as dryness of mouth and sedation, respectively. Bilastine, desloratadine, and levocetirizine are second-generation antihistamines which have variable effects on dryness of mouth and sedation; hence, the objective of this study is to evaluate any differences in these effects in chronic urticaria patients prescribed the above-mentioned antihistamine drugs.

Methods: Subjects with chronic urticaria who were prescribed any of the three antihistamines by the dermatologist were enrolled. Baseline readings of salivary flow by cotton ball method and psychometric performances by digit letter substitution test (DLST), six letter cancellation test (SLCT), card sorting test, and Visual Analog Scale (VAS) for dryness of mouth and sedation measured before administration of prescribed antihistaminic drug and compared with readings taken of the same tests after 7 days of antihistaminic drug administration.

Results: A total of 36 subjects were enrolled median age of 38.5 years (range 18–57 years) and 55% (20/36) were males. Reduction in the mean salivary flow and the psychomotor performance were not significantly different between the three drug groups, although there were reductions in the three groups in the outcome measures salivary flow and psychomotor performance tests including DLST and SLCT when compared to baseline.

Conclusion: The three drugs are similar with respect to their adverse effect profile in terms of causing dryness of mouth and impairment of psychomotor performance.

Downloads

Download data is not yet available.

References

Greaves MW. Antihistamines in dermatology. Skin Pharmacol Physiol. 2005 Oct 1;18(5):220-9. doi: 10.1159/000086667, PMID: 16015020

Gengo FM, Dabronzo J, Yurchak A, Love S, Miller JK. The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine. Clin Pharmacol Ther. 1987;42(3):265-72. doi: 10.1038/clpt.1987.145, PMID: 2887328

Qidwai JC, Watson GS, Weiler JM. Sedation, cognition, and antihistamines. Curr Allergy Asthma Rep. 2002 May;2(3):216-22. doi: 10.1007/s11882-002-0022-1, PMID: 11918863

Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol. 2000 Jun;105(6 Pt 2):S622-7. doi: 10.1067/ mai.2000.106153, PMID: 10856168

Yanai K, Ryu JH, Watanabe T, Iwata R, Ido T, Sawai Y, et al. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography. Br J Pharmacol. 1995;116(1):1649-55. doi: 10.1111/j.1476-5381.1995. tb16386.x, PMID: 8564232

Danjou P, Molinier P, Berlin I, Patat A, Rosenzweig P, Morselli PL. Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects. Br J Clin Pharmacol. 1992;34(4):328-31. doi: 10.1111/j.1365-2125.1992.tb05638.x, PMID: 1360807

Patat A, Perault MC, Vandel B, Ulliac N, Zieleniuk I, Rosenzweig P. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers. Br J Clin Pharmacol. 1995;39(1):31-8. doi: 10.1111/j.1365- 2125.1995.tb04406.x, PMID: 7756096

Riedel WJ, Van Veggel, O’Hanlon JF. Cetrizine 10 and 20 mg impair psychomotor performance. Clin Exp Allergy. 1990;20(Suppl 1):97.

Pechardre JC, Beudin P, Eschalier A, Trolese JF, Rihoux. A comparison of central and peripheral effects of cetirizine and loratadine. J Int Med Res. 1991;19:289-95.

Danjou PH, Dunmore C, Curson VH, Rosenzweig P, Hindmarch I, Morselli PL. A double-blind placebo control of study of the psychometric effect of the SL. 85.0324 a new H1 antagonist drug compared to terfinadine and tripolidine in healthy subjects. Eur J Pharmacol. 1990;183(2):534. doi: 10.1016/0014-2999(90)93439-W

Published

07-03-2025

How to Cite

IMRAN KHAN, et al. “A STUDY TO EVALUATE THE EFFECTS OF MULTIPLE ORAL DOSES OF BILASTINE, DESLORATADINE, AND LEVOCETIRIZINE ON PSYCHOMOTOR PERFORMANCE AND SALIVARY FLOW IN PATIENTS WITH CHRONIC URTICARIA ATTENDING DERMATOLOGY OUTPATIENT DEPARTMENT AT A TERTIARY CARE CENTER”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 3, Mar. 2025, pp. 124-9, doi:10.22159/ajpcr.2025v18i3.53701.

Issue

Section

Original Article(s)